Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

A Two-Delivery Model Examining Upright Positioning During Labor: A Cost-Effectiveness Analysis [34C]

Hersh, Alyssa R., BS, BA; Greiner, Karen Scrivner, BA; Gallagher, Alexandra C., BA; Tilden, Ellen, PhD, CNM; Caughey, Aaron B., MD, PhD

Obstetrics & Gynecology: May 2018 - Volume 131 - Issue - p 39S
doi: 10.1097/01.AOG.0000532974.71558.31
Friday, April 27, 2018

INTRODUCTION: Studies have demonstrated the benefits of an upright and mobile position during labor, including lower risk for cesarean delivery and shortened time in labor. We sought to examine the cost-effectiveness and outcomes associated with laboring upright during the first delivery and the resultant effects on the second delivery, such that the risks, benefits, and costs are framed within the public health perspective of the average US childbearing woman’s entire reproductive course.

METHODS: A cost-effectiveness model using TreeAge software was designed using a theoretical cohort of 1.8 million women, the approximate number of nulliparous term births in the US annually, including uncomplicated deliveries with a trial of labor and with all women having a second delivery, reflecting the average number of births per woman in the US. Outcomes included mode of delivery, maternal death, uterine rupture and hysterectomy, in addition to cost and quality-adjusted life years (QALY) for both pregnancies. Probabilities were derived from the literature, and a cost-effectiveness threshold was set at $100,000/QALY.

RESULTS: We found that allowing women to be upright and mobile during her first labor resulted in fewer cesarean deliveries, reduced costs and improved QALYs for both the first and subsequent delivery. In our theoretical cohort, laboring upright led to 64,890 fewer cesarean deliveries, 15 fewer maternal deaths, 113 fewer uterine ruptures, and 30 fewer hysterectomies, saving $785 million with 7,227 increased QALYs.

CONCLUSION: Laboring upright is a no-cost intervention that leads to improved outcomes, decreased costs, and increased QALYs during a woman’s first and second delivery.

Oregon Health & Science University, Portland, OR

Financial Disclosure: Aaron Caughey disclosed the following—Celmatix: Consultant/Advisory Board, Ownership Interest; Mindchild: Consultant/Advisory Board, Ownership Interest. The other authors did not report any potential conflicts of interest.

© 2018 by American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.